The store will not work correctly when cookies are disabled.
N-(1-(cyclopropylmethyl)-1H-imidazo[4,5-c]pyridin-6-yl)-2-methylbenzo[d]oxazol-5-amine
ID: ALA4776208
PubChem CID: 162643718
Max Phase: Preclinical
Molecular Formula: C18H17N5O
Molecular Weight: 319.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2cc(Nc3cc4c(cn3)ncn4CC3CC3)ccc2o1
Standard InChI: InChI=1S/C18H17N5O/c1-11-21-14-6-13(4-5-17(14)24-11)22-18-7-16-15(8-19-18)20-10-23(16)9-12-2-3-12/h4-8,10,12H,2-3,9H2,1H3,(H,19,22)
Standard InChI Key: YJVUAYVRDJQBCX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 28 0 0 0 0 0 0 0 0999 V2000
31.4481 -9.6205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4469 -10.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1550 -10.8490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1532 -9.2117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8618 -9.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8621 -10.4356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6407 -10.6883 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.1217 -10.0258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6403 -9.3638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8935 -11.4654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6928 -11.6351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7389 -10.8481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0315 -10.4389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0367 -9.6219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3301 -9.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3302 -10.8477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2978 -12.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4675 -11.3794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6231 -10.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6208 -9.6241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8420 -9.3735 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3629 -10.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8457 -10.6972 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.5457 -10.0391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 20 2 0
19 16 2 0
16 13 1 0
17 11 1 0
18 17 1 0
11 18 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 19 1 0
22 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 319.37 | Molecular Weight (Monoisotopic): 319.1433 | AlogP: 4.03 | #Rotatable Bonds: 4 |
Polar Surface Area: 68.77 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.55 | CX LogP: 2.55 | CX LogD: 2.54 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.61 | Np Likeness Score: -1.41 |
References
1. Lewis A,Beresford A,Chambers MS,Clark G,Hartley DC,Hirst KL,Higashino M,Kawahadara S,Nakanishi M,Saito T,Imagawa A,Habashita H,Maidment S,Macleod AM,Owens AP,Rae A,Rouse C,Wishart G. (2020) Discovery of ONO-8590580: A novel, potent and selective GABA α negative allosteric modulator for the treatment of cognitive disorders., 30 (22): [PMID:32898695] [10.1016/j.bmcl.2020.127536] |